Financhill
Sell
38

CRVS Quote, Financials, Valuation and Earnings

Last price:
$4.28
Seasonality move :
24.78%
Day range:
$3.17 - $3.49
52-week range:
$1.75 - $10.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.01x
Volume:
4.7M
Avg. volume:
1000K
1-year change:
70.92%
Market cap:
$228.3M
Revenue:
--
EPS (TTM):
-$0.97

Earnings Data

Next earnings date for CRVS
Aug 06
2025
Most recent earnings per share
-$0.18
Missed by $0.06
(Mar 25/2025)
Consensus Estimate
-$0.12
(Mar 25/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRVS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 -- -- -- -$0.11 --
05/08/2025 Q1 -- -- -- -$0.12 --
03/25/2025 Q4 -- -- -$0.18 -$0.12 -$0.06
11/12/2024 Q3 -- -- -$0.60 -$0.12 -$0.48
08/06/2024 Q2 -- -- -$0.07 -$0.12 $0.05
05/06/2024 Q1 -- -- -$0.12 -$0.13 $0.01
03/19/2024 Q4 -- -- -$0.13 -$0.13 -$0.00
11/07/2023 Q3 -- -- -$0.12 -$0.12 $0.00
08/08/2023 Q2 -- -- -$0.14 -$0.14 --
05/08/2023 Q1 -- -- -$0.17 -$0.17 --
03/28/2023 Q4 -- -- -$0.21 -$0.23 $0.02
11/03/2022 Q3 -- -- -$0.32 -$0.15 -$0.18
08/08/2022 Q2 -- -- -$0.18 -$0.18 -$0.00
05/05/2022 Q1 -- -- -$0.18 -$0.15 -$0.03
03/10/2022 Q4 -- -- -$0.20 -$0.18 -$0.02
11/01/2021 Q3 -- -- -$0.24 -$0.24 -$0.00
08/02/2021 Q2 -- -- -$0.28 -$0.31 $0.03
04/29/2021 Q1 -- -- -$0.34 -$0.32 -$0.03
03/25/2021 Q4 -- -- $0.92 -$0.33 $1.25
10/29/2020 Q3 -- -- -$0.33 -$0.22 -$0.11
07/30/2020 Q2 -- -- -$0.36 -$0.24 -$0.12
04/30/2020 Q1 -- -- -$0.44 -$0.41 -$0.04
03/05/2020 Q4 -- -- -$0.38 -$0.31 -$0.07
10/29/2019 Q3 -- -- -$0.37 -$0.43 $0.06
08/01/2019 Q2 -- -- -$0.44 -$0.44 -$0.00
05/09/2019 Q1 -- -- -$0.40 -$0.48 $0.08
03/07/2019 Q4 -- -- -$0.36 -$0.50 $0.14
11/01/2018 Q3 -- -- -$0.36 -- --
08/02/2018 Q2 -- -- -$0.40 -- --
05/03/2018 Q1 -- -- -$0.63 -- --
03/01/2018 Q4 -- -- -$0.58 -- --
11/02/2017 Q3 -- -- -$0.62 -- --
08/03/2017 Q2 -- -- -$0.73 -- --
05/04/2017 Q1 -- -- -$0.79 -- --
12/31/2016 Q4 -- -- -$0.55 -- --
11/03/2016 Q3 -- -- -$0.51 -- --
06/30/2016 Q2 -- -- -$0.43 -- --
05/05/2016 Q1 -- -- -$5.39 -- --
12/31/2015 Q4 -- -- -$0.30 -- --
09/30/2015 Q3 -- -- -$0.35 -- --
06/30/2015 Q2 -- -- -$2.27 -- --

Corvus Pharmaceuticals Earnings Questions

  • How Much did Corvus Pharmaceuticals Generate in Revenue Last Quarter?

    Corvus Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Corvus Pharmaceuticals Beat Earnings Last Quarter?

    Corvus Pharmaceuticals announced earnings per share of -$0.18 which represents a miss of analyst forecast a -$0.12 per share.

  • Is Corvus Pharmaceuticals Profitable?

    Corvus Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Corvus Pharmaceuticals EPS Next Year?

    Corvus Pharmaceuticals's earnings are forecast to decrease from -$1.02 per share to -$0.92 per share next year representing a decrease of -54.51%.

  • When is Corvus Pharmaceuticals's Earnings Date?

    Corvus Pharmaceuticals's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 4.67% over the past day.

Buy
52
QDEL alert for May 9

QuidelOrtho [QDEL] is down 0.8% over the past day.

Buy
61
TPC alert for May 9

Tutor Perini [TPC] is up 4.95% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock